Decrease in the incidence of total hip arthroplasties in patients with rheumatoid arthritis - results from a well defined population in south Sweden
Korosh Hekmat,Lennart T H Jacobsson,Jan-Åke Nilsson,Ingemar F Petersson,Otto Robertsson,Göran Garellick,Carl Turesson +6 more
TL;DR: This investigation shows a significant decrease in the incidence of total hip arthroplasties in patients with RA after 2001, and possible explanations include a positive effect on joint damage from more aggressive pharmacological treatment.
read more
Abstract: Introduction
One aim of modern pharmacologic treatment in rheumatoid arthritis (RA) is to prevent joint destruction and reduce the need for surgery. Our purpose was to investigate secular trends in the incidence of primary total hip and knee arthroplasties in a well defined sample of patients with RA.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Increased risk of complications following total joint arthroplasty in patients with rheumatoid arthritis.
Bheeshma Ravi,Ruth Croxford,Simon Hollands,J. Michael Paterson,Earl R. Bogoch,Hans J. Kreder,Gillian A. Hawker +6 more
TL;DR: Using a validated algorithm for identifying patients with RA, this study compares the rates of complications among THA and TKA recipients between those with RA and those without RA.
186
Has Total Hip Arthroplasty in Patients 30 Years or Younger Improved? A Systematic Review
TL;DR: This review of the literature demonstrates an improvement in radiographic outcomes and survivorship of THA, but no significant differences in pain and function scores, in very young patients treated over the past two decades when compared with historical controls.
122
Orthopedic Surgery Among Patients with Rheumatoid Arthritis 1980-2007: A Population-based Study Focused on Surgery Rates, Sex, and Mortality
TL;DR: The rates of joint surgery continue to decrease for patients more recently diagnosed with RA and JRP is associated with increased mortality, which may reflect improved treatments for RA as well as continued higher disease burden among some patients.
110
Countrywise results of total hip replacement An analysis of 438,733 hips based on the Nordic Arthroplasty Register Association database
Keijo T Mäkelä,Markus Matilainen,Pekka Pulkkinen,Anne Marie Fenstad,Leif Ivar Havelin,Lars B. Engesæter,Ove Furnes,Søren Overgaard,Alma B Pedersen,Johan Kärrholm,Henrik Malchau,Göran Garellick,Jonas Ranstam,Antti Eskelinen +13 more
TL;DR: The differences in THR survival rates were considerable, with inferior results in Finland, and brand-level comparison of THRs in Nordic countries will be required.
The decline in joint replacement surgery in rheumatoid arthritis is associated with a concomitant increase in the intensity of anti-rheumatic therapy: A nationwide register-based study from 1995 through 2010
TL;DR: The data suggest that effective medical therapy is the most likely explanation for this favorable development of joint replacements in rheumatoid arthritis, and indicate that the use of joint replacement in RA has decreased dramatically.
97
References
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.
Frank C. Arnett,Steven M. Edworthy,Daniel A. Bloch,Dennis J. McShane,James F. Fries,Norman S. Cooper,L. A. Healey,Stephen R. Kaplan,Matthew H. Liang,Harvinder S. Luthra,Thomas A. Medsger,Donald M. Mitchell,David H. Neustadt,Robert S. Pinals,Jane G. Schaller,John T. Sharp,Ronald L. Wilder,Gene G. Hunder +17 more
TL;DR: The revised criteria for the classification of rheumatoid arthritis (RA) were formulated from a computerized analysis of 262 contemporary, consecutively studied patients with RA and 262 control subjects with rheumatic diseases other than RA (non-RA).
20.8K
Revised criteria for the classification of rheumatoid arthritis.
TL;DR: The Bulletin on the Rheumatic Diseases has published all of the classification criteria for rheumatic diseases to date as mentioned in this paper, and these new revised classification criteria are very important as they should provide understanding of the possibly changing face of rheumatoid arthritis.
8.4K
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
Peter E. Lipsky,D. van der Heijde,E W St Clair,Daniel E. Furst,F. C. Breedveld,J. R. Kalden,Josef S. Smolen,M Weisman,Paul Emery,Marc Feldmann,Gregory Harriman,Ravinder Nath Maini +11 more
TL;DR: In patients with persistently active rheumatoid arthritis despite methotrexate therapy, repeated doses of infliximab in combination with methotRexate provided clinical benefit and halted the progression of joint damage.
3.2K
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
Lars Klareskog,Désirée van der Heijde,Julien P de Jager,A. K. S. Gough,Joachim R. Kalden,Michel Malaise,Emilio Martin Mola,Karel Pavelka,Jacques Sany,L. Settas,Joseph Wajdula,Ronald Pedersen,Saeed Fatenejad,Marie Sanda +13 more
TL;DR: The combination of etanercept and methotrexate was significantly better in reduction of disease activity, improvement of functional disability, and retardation of radiographic progression compared with methotRexate or etanorcept alone.
1.9K
•Journal Article
Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis
Lennart Jacobsson,Carl Turesson,Anders Gülfe,Meliha C Kapetanovic,Ingemar F Petersson,Tore Saxne,Pierre Geborek +6 more
TL;DR: It is suggested that the risk of developing CVD is lower in patients with RA treated with TNF blockers, compatible with the hypothesis that inflammation contributes to the development of cardiovascular events.
580